Lateral flow assay: a promising rapid point-of-care testing tool for infections and non-communicable diseases
Asian Biomedicine · 01.12.2023 · 17 (6) · 250-266
DOI: 10.2478/abm-2023-0068 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Asian Biomedicine, online erschienen am 28.12.2023. Verfasst von Kumaravel Vealan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Science, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, UPM Serdang 43400, Malaysia. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The point-of-care testing (POCT) approach has established itself as having remarkable importance in diagnosing various infectious and non-communicable diseases (NCDs). The POCT approach has succeeded in meeting the current demand for having diagnostic strategies that can provide fast, sensitive, and highly accurate test results without involving complicated procedures. This has been accomplished by introducing rapid bioanalytical tools or biosensors such as lateral flow assays (LFAs). The production cost of these tools is very low, allowing developing countries with limited resources to utilize them or produce them on their own. Thus, their use has grown in various fields in recent years. More importantly, LFAs have created the possibility for a new era of incorporating nanotechnology in disease diagnosis and have already attained significant commercial success worldwide, making POCT an essential approach not just for now but also for the future. In this review, we have provided an overview of POCT and its evolution into the most promising rapid diagnostic approach. We also elaborate on LFAs with a special focus on nucleic acid LFAs.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biomedical Science, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, UPM Serdang 43400, Malaysia.
- Department of Medical Microbiology, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, UPM Serdang 43400, Malaysia.
- Department of Chemistry Malaysia, Ministry of Science, Technology and Innovation, Petaling Jaya 46661, Selangor, Malaysia.
- Centre for Chemical Biology and Therapeutics, Institute for Stem Cell Science and Regenerative Medicine, Bangalore 560065, India.
- Malaysian Research Institute on Ageing (MyAgeing), Universiti Putra Malaysia, UPM Serdang 43400, Selangor, Malaysia.
Zitieren
APA
Vealan, K., Joseph, N., Alimat, S., Karumbati, A. S., & Thilakavathy, K. (2023). Lateral flow assay: a promising rapid point-of-care testing tool for infections and non-communicable diseases. Asian Biomedicine, 17(6), 250-266. https://doi.org/10.2478/abm-2023-0068
Vancouver
Vealan K, Joseph N, Alimat S, Karumbati AS, Thilakavathy K. Lateral flow assay: a promising rapid point-of-care testing tool for infections and non-communicable diseases. Asian Biomedicine. 2023;17(6):250-266. doi:10.2478/abm-2023-0068
BibTeX
@article{Vealan2023,
author = {Vealan, Kumaravel and Joseph, Narcisse and Alimat, Sharizah and Karumbati, Anandi S and Thilakavathy, Karuppiah},
title = {Lateral flow assay: a promising rapid point-of-care testing tool for infections and non-communicable diseases},
journal = {Asian Biomedicine},
year = {2023},
volume = {17},
number = {6},
pages = {250--266},
doi = {10.2478/abm-2023-0068}
}
EUVIMED